NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)
Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)
RecruitingN/A
Sponsor: UNICANCER
Conditions: Lung Cancer
Countries: France
This database compiles data from existing data available from patient's electronic medical records (EMR) at the 38 participating hospitals (20 French comprehensive cancer centers and 18 public hospitals).
Eligibility overview
Sex: ALL
Age: 18 Years to —
Healthy volunteers: No
Study type: OBSERVATIONAL
Eligibility criteria
Inclusion criteria : * Adult (over 18) * Treated (with radiotherapy or systemic anti-cancer treatment) for a lung cancer or diagnosed with metastatic lung cancer over the selection period at one of the participating site Exclusion criteria \- None
Locations (21)
- Angers, France
- Bordeaux, France
- Caen, France
- Clermont-Ferrand, France
- Créteil, France
- Dijon, France
- Lille, France
- Lyon, France
- Marseille, France
- Montpellier, France
- Mulhouse, France
- Nantes, France
- Nice, France
- Paris, France
- Reims, France
- Rouen, France
- Saint-Cloud, France
- Strasbourg, France
- Toulouse, France
- Vandœuvre-lès-Nancy, France
- Villejuif, France